CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Ordinary shares	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Total
Beginning balance at Dec. 31, 2024	$ 17	$ 1,193,010	$ 914	$ (329,098)	$ 864,843
Beginning balance (in shares) at Dec. 31, 2024	171,860
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of ordinary shares upon exercise of vested share options		965			965
Issuance of ordinary shares upon exercise of vested share options (in shares)	644
Issuance of ordinary shares upon vesting of restricted share units (in shares)	134
Shares withheld for taxes		(156)			(156)
Shares withheld for taxes (in shares)	(28)
Share-based compensation expense		5,918			5,918
Unrealized loss on investments, net			(99)		(99)
Net loss				(46,833)	(46,833)
Ending balance at Mar. 31, 2025	$ 17	1,199,737	815	(375,931)	824,638
Ending balance (in shares) at Mar. 31, 2025	172,610
Beginning balance at Dec. 31, 2025	$ 21	1,985,602	1,054	(470,300)	1,516,377
Beginning balance (in shares) at Dec. 31, 2025	212,513
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of ordinary shares upon exercise of vested share options		869			869
Issuance of ordinary shares upon exercise of vested share options (in shares)	231
Issuance of ordinary shares upon vesting of restricted share units (in shares)	586
Shares withheld for taxes		(2,574)			(2,574)
Shares withheld for taxes (in shares)	(122)
Share-based compensation expense		11,639			11,639
Unrealized loss on investments, net			(3,249)		(3,249)
Net loss				(75,968)	(75,968)
Ending balance at Mar. 31, 2026	$ 21	$ 1,995,536	$ (2,195)	$ (546,268)	$ 1,447,094
Ending balance (in shares) at Mar. 31, 2026	213,208